Aducanumab
—the New Alzheimer’s Drug
It’s the first FDA approved drug in decades to help people with Alzheimer’s. So why are caregivers so concerned?
Patients and their families are starting to inquire about the new Alzheimer's drug approved this week by the US Food and Drug Administration. Shipments of the medication are expected to go out in just a couple of weeks.
How does it work?
Many molecular and cellular changes happen in the brain of someone with Alzheimer's disease. This drug is supposed to help with certain characteristics of the disease, including the buildup of plaques in the brain, made of proteins called beta amyloid.
But there is mounting controversy around drug effectiveness and cost. That’s got a number of people who routinely work with aging populations concerned.
This week on OnPoint on WACH— Aducanumab— the New Alzheimer’s Drug. It’s the first FDA approved drug in decades to help people with Alzheimer’s. So why are caregivers so concerned?
